Navigation Links
New Trial Will Test Virus-Delivered Treatment for Mesothelioma, According to Surviving Mesothelioma

Researchers from multiple Japanese universities are recruiting patients for the first human trials of a new approach to treating mesothelioma by “turning off” cell growth signaling. Surviving Mesothelioma has just posted the full story. Click here to read it now.

The experimental treatment involves manipulating the growth of mesothelioma cells with an injection of an altered virus. The virus has been manipulated to express a gene that interferes with the signals that tell cancer cells to grow and multiply.

“The clinical investigation is a first-in-human trial to use the NK4 gene and to block the HGF/c-Met pathway with gene medicine,” writes lead investigator Yugi Tada of Chiba University. “These data will be crucial to judge whether local production of NK4 molecules can be an anti-cancer strategy.”

The researchers recently laid out their study protocol, which will utilize a common virus called adenovirus as a delivery system for genetic information, on Springerplus.

“Although it is not yet part of the standard approach for mesothelioma, virotherapy has shown great promise in the treatment of other types of cancer, often with fewer serious side effects than other forms of therapy,” says Surviving Mesothelioma Managing Editor Alex Strauss.

To understand how the Ad-NK4 treatment may combat mesothelioma, as well as the findings of a related study, see Could a Virus-Delivered Gene Slow Mesothelioma Growth? now available on the Surviving Mesothelioma website.

Tada, Y, “A clinical protocol to inhibit the HGF/c-Met pathway for malignant mesothelioma with an intrapleural injection of adenoviruses expressing the NK-4 gene”, July 16, 2015, Springerplus, eCollection,

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Read the full story at

Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. FDAnews Announces — Mastering Social Media for Clinical Trial Recruitment On-Demand Webinar, Aug. 26, 2015
2. “Bionic Eye” Implant for the Blind Proved Safe and Effective at the End of a Three Year Clinical Trial
3. UofL Physicians Conducting Vaccine Trial for Children with Relapsed Tumors at Kosair Children’s Hospital
4. Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available
5. BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial
6. The Vision Enhancing “Bionic Eye” Deemed Safe For Long Term Use After Three Year Clinical Trial
7. Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch
8. Joint Pain Therapeutics Clinical Trials Review H1 2015 Market Research Report Available at
9. Quorum Review IRB Launches New Program for Phase I Healthy Clinical Trials
10. FDAnews Announces — Think Like a Clinical Trial Site Auditor: Strategies for Successful Monitoring Webinar, July 29, 2015
11. Positive Data Announced in Phase IIb Clinical Trial of Cystic Fibrosis Gene Therapy Manufactured by VGXI, Inc.
Post Your Comments:
(Date:9/18/2019)... ... , ... A new study by BestPlaces looks at ten indicators to produce the first ranking ... so other related rights vary widely across the 50 states. , Ten topics ... orientation) , Employment , Education , Gender Marker Updates ...
(Date:9/17/2019)... ... 17, 2019 , ... Since the registration of the NociScan ... in the US, Nocimed has been marketing its unique technology to healthcare clinicians ... MRI equipment to perform MR spectroscopy, NociScan detects the presence of chemical biomarkers ...
(Date:9/17/2019)... N.Y. (PRWEB) , ... September 17, 2019 , ... ... medicine cabinet could help extend the lives of some cancer patients? In companion ... Chicago, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose ...
(Date:9/17/2019)... ... 17, 2019 , ... The Center for Information and Study ... third edition of The Gift of Participation. Written by CISCRP Founder, Ken Getz, ... navigate the clinical research process. The new edition offers a fresh look at ...
(Date:9/12/2019)... (PRWEB) , ... September 12, 2019 , ... ... both a local and national scale in two recent and well-renowned listing publications, ... fastest-growing privately held businesses for the 2019 year. , Dr. Jeffrey Donaldson, ...
Breaking Medicine News(10 mins):
(Date:9/22/2019)... (PRWEB) , ... September 22, 2019 , ... ... Bellevue, WA offering the highest level of both plastic surgery and non-surgical aesthetic ... FDA-cleared microneedling device. Microneedling is a proven skin rejuvenation treatment that uses tiny ...
(Date:9/18/2019)... WASHINGTON, Pa. (PRWEB) , ... ... ... Inc. (USH), parent organization to ReachMD, Global Learning Collaborative, and other healthcare-focused ... digital learning environment, DecisionSim™, uses real-world cases to challenge healthcare professionals (HCPs) ...
(Date:9/17/2019)... (PRWEB) , ... September 18, 2019 , ... Uniform ... Beyond Breast Cancer to raise funds for Breast Cancer programs and services. , This ... 42,000 will die of the disease. During the month of October 2019, Uniform Advantage ...
Breaking Medicine Technology: